Leverantör: KERENDIA
Kerendia 10mg Tablets 28'S
Beskrivning
Iihyaf tgfwsbfytiqw trf68qI
indicated to reduce the risk of sustained eGFR decline, end stage kidney
disease, cardiovascular death, non-fatal myocardial infarction, and
hospitalization for heart failure in adult patients with chronic kidney disease
(CKD) associated with type 2 diabetes (T2D)
erendia is a non-steroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D)
erendia is a non-steroidal mineralocorticoid receptor antagonist (MRA)indicated to reduce the risk of sustained eGFR decline, end stage kidney
disease, cardiovascular death, non-fatal myocardial infarction, and
hospitalization for heart failure in adult patients with chronic kidney disease
(CKD) associated with type 2 diabetes (T2D)
